Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22.

08:00 EDT 13th June 2019 | BioPortfolio

Summary of "Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22."

Interleukin (IL)-10 plays key role in controlling intestinal inflammation. IL-10-deficient mice and patients with mutations in IL-10 or its receptor, IL-10R, show increased susceptibility to inflammatory bowel diseases (IBD). Protein tyrosine phosphatase PTPN22 controls immune cell activation and the equilibrium between regulatory and effector T cells, playing important role in controlling immune homeostasis of the gut. Here, we examined the role of PTPN22 in intestinal inflammation of IL-10-deficient (IL-10 ) mice. We crossed IL-10 mice with PTPN22 mice to generate PTPN22 IL-10 double knock-out mice and induced colitis with dextran-sodium sulfate (DSS). In line with previous reports, DSS-induced acute and chronic colitis was exacerbated in IL-10 mice as compared to wild-type (WT) controls. However, PTPN22 IL-10 double knock-out mice developed milder disease as compared to IL-10 mice. IL-17-promoting innate cytokines and Th17 cells were markedly increased in PTPN22 IL-10 mice, but did not provide a protective function. CXCL1/KC was also increased in PTPN22 IL-10 mice, but therapeutic injection of CXCL1/KC in IL-10 mice did not ameliorate colitis. These results show that PTPN22 promotes intestinal inflammation in IL-10-deficient mice, suggesting that therapeutic targeting of PTPN22 might be beneficial in patients with IBD and mutations in IL-10 and IL-10R. This article is protected by copyright. All rights reserved.


Journal Details

This article was published in the following journal.

Name: Clinical and experimental immunology
ISSN: 1365-2249


DeepDyve research library

PubMed Articles [14951 Associated PubMed Articles listed on BioPortfolio]

Aquaporin 4 deficiency alleviates experimental colitis in mice.

Aquaporin (AQP) 4 is expressed in the basolateral membrane of colonic epithelial cells, and the purpose of this study was to explore the mechanistic role of AQP4 in experimental colitis. Experimental ...

Antibiotics exacerbated colitis by affecting the microbiota, Treg cells and SCFAs in IL10-deficient mice.

Many studies have shown that antibiotic therapy can attenuate colitis in IL10-deficient (IL10) mice. However, these results have indicated that antibiotics were more successful in preventing, rather t...

Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.

Autotaxin (ATX or ENPP2) is a secreted lysophospholipase D that produces lysophosphatidic acid (LPA), a pleiotropic lipid mediator acting on specific GPCRs. ATX and LPA have been implicated in key (pa...

Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses.

P28GST, a 28Kd glutathione S-transferase enzymatic protein derived from a schistosome helminth prevents experimental colitis when administered subcutaneously in the presence of adjuvant by decreasing ...

Effect of fecal microbiota transplantation on experimental colitis in mice.

The aim of the present study was to investigate the effect of fecal microbiota transplantation (FMT) on the acute inflammatory response in a murine model of dextran sulfate sodium (DSS)-induced coliti...

Clinical Trials [4033 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis

This study will evaluate the effectiveness and safety of the experimental compound OP2000 (deligoparin) in patients with active ulcerative colitis. Patients eligible for this study will ...

Risk Factors for Microscopic Colitis

Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unkno...

Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo

Our data indicate that the CFTR-molecule functions as a transporter for sphingosine-1-phosphate and sphingosine or regulates the uptake of these sphingolipids by epithelial cells. The dist...

Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis

The purpose of this study is to determine if taking Asacol once a day is as effective as taking Asacol twice or three times a day in keeping ulcerative colitis inactive, and to determine w...

CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)

Casein glycomacropeptide (CGMP) has anti-inflammatory properties in experimental rodent colitis and using human in vitro inflammation models. Its use as a food ingredient has proven safe a...

Medical and Biotech [MESH] Definitions

A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.

Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.

Myelin-deficient mutants which are from the inbred Tabby-Jimpy strain.

An experimental sarcoma of mice.

An experimental sarcoma of mice.

Quick Search


DeepDyve research library

Searches Linking to this Article